1155773-15-1

1155773-15-1 structure

Name: ER 819762
Chemical Name: ER819762
CAS Number: 1155773-15-1
Molecular Formula: C₃₀H₃₉N₃O₃
Molecular Weight: 489.649
Catalog: Signaling Pathways GPCR/G Protein Prostaglandin Receptor
Create Date: 2020-01-11 17:45:49
Modify Date: 2024-07-22 09:45:52
ER-819762 is a novel potent, selective, orally active EP4 receptor antagonist with IC50 of 59 nM in cAMP-dependent reporter assay; inhibits EP4-stimulated Th1 differentiation, Th17 cell expansion, and IL-23 secretion by activated dendritic cells; exhibits no agonism or antagonism for the related PGE2 EP1, EP2 and EP3 receptors; suppresses Th1 and Th17 cytokine production, suppresses disease in collagen- and GPI-induced arthritis in mice, and suppresses CFA-induced inflammatory pain in rats.

Name	ER819762
Synonyms	(10S)-1'-(3,5-Dimethylbenzyl)-2-ethyl-7,9-dimethoxy-10-methyl-5,10-dihydrospiro[imidazo[1,5-b][2]benzazepine-1,4'-piperidin]-3(2H)-one ER819762 Spiro[1H-imidazo[1,5-b][2]benzazepine-1,4'-piperidin]-3(2H)-one, 1'-[(3,5-dimethylphenyl)methyl]-2-ethyl-5,10-dihydro-7,9-dimethoxy-10-methyl-, (10S)-

Description	ER-819762 is a novel potent, selective, orally active EP4 receptor antagonist with IC50 of 59 nM in cAMP-dependent reporter assay; inhibits EP4-stimulated Th1 differentiation, Th17 cell expansion, and IL-23 secretion by activated dendritic cells; exhibits no agonism or antagonism for the related PGE2 EP1, EP2 and EP3 receptors; suppresses Th1 and Th17 cytokine production, suppresses disease in collagen- and GPI-induced arthritis in mice, and suppresses CFA-induced inflammatory pain in rats.
References	References 1. Chen Q, et al. Br J Pharmacol. 2010 May;160(2):292-310. 2. Jones VC, et al. Br J Pharmacol. 2016 Mar;173(6):992-1004. View Related Products by Target Prostaglandin Receptor